The revival of cancer vaccines - The eminent need to activate humoral immunity
In light of the increasing number of approved monoclonal antibodies for the treatment of cancer, it seems peculiar that the development of antibody inducing vaccines gets so little attention. In our view there is a tremendous opportunity in the development of cancer vaccines inducing humoral immune...
Saved in:
Main Authors: | Elisabeth J. M. Huijbers (Author), Arjan W. Griffioen (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current perspectives in assessing humoral immunity after measles vaccination
by: Iana H. Haralambieva, et al.
Published: (2019) -
Emin Pasha
by: Plehn, M. C.; Upton, George P. (George Putnam), 1834-1919 [Translator] -
Eminent Victorians
by: Strachey, Lytton, 1880-1932 -
Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients
by: Sandra Hasmann, et al.
Published: (2021) -
Characterization of humoral and cellular immune features of gamma-irradiated influenza vaccine
by: Fengjia Chen, et al.
Published: (2021)